RMDResMed
Is it safe?
Strong, no red flags: a safe balance sheet, clean books, and quality strong.
Financially healthy, low distress risk Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.
Reported earnings show no manipulation flags Beneish M-score, a forensic model that detects earnings-manipulation patterns (receivables outrunning sales, margins slipping, accrual-heavy profit).
High fundamental quality Piotroski F-score, nine pass/fail tests of year-over-year financial health across profitability, balance sheet and efficiency. 7 to 9 is strong, 0 to 3 weak.
Insiders were net sellers (-$4.2M, 90 days to Oct 22, 2026), selling is often routine.
Net cash and profitable. A rule of thumb on leverage, not a credit rating.
Moderate price swings, typical volatility. Worst drawdown -54% · now 8% below its 52-week high.
Unless marked, from SEC EDGAR, as of Jun 30, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can RMD take a bad year?
ResMed holds $810M more cash than debt, so a bad year is a question about profits, not about lenders.
Net cash · as at Q4 2026 · cash and short-term investments less total debt
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Altman Z-score
- 12.04
Altman Z-score · safe zone, above 3
- Debt / equity
- 0.10×
Debt / equity
Details›
- Total debtQ4 2026
- $659M
- Cash and short-term investments
- $1.47B
- Net cash
- $810M
- EBITDA, trailing twelve months
- $2.09B
- Operating profit, trailing twelve months
- $1.89B
- Debt / equity
- 0.10×
- Total debt / EBITDA
- 0.32×
- Annualised volatilitytwo years of daily moves
- 28%
- Worst drawdown on file
- −54%
- Below its 52-week high
- 7.9%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
The balance sheet
What it owes against what it owns, and how close that comes to trouble.
How far can it fall?
How much the price moves, how deep and how long its falls have run, and what each unit of risk has paid.
Medical Instruments & Supplies
The closest names by size in the same industry